The metabolome, RNA sequencing, ChIP, WGBS and WGS data of JIMT1, SKBR3 and MCF10A.

This research integrated metabolomics, transcriptomics and epigenomics data of trastuzumab sensitive and primary resistant HER2 positive breast cancer to identify metabolic alterations.本研究整合了曲妥珠单抗（trastuzumab）敏感及原发性耐药的HER2阳性乳腺癌的代谢组学（metabolomics）、转录组学（transcriptomics）与表观基因组学（epigenomics）数据，以识别相关代谢改变。